← Leaderboards
Scott R Floyd
Massachusetts Institute Of Technology
$4,076,884
Attributed
$9,160,245
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2008–24$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,160,245 · 6
By mechanism
U01$4,598,428 · 1
R01$2,553,955 · 1
R38$1,046,079 · 1
R21$961,783 · 3
Top collaborators
- Albert Sidney Baldwin4 shared
- Catherine T Flores4 shared
- Shawn Hingtgen4 shared
- Douglas A Marchuk4 shared
- Mark Oldham1 shared
- Ying Wu1 shared
- Michael B Yaffe1 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Mike Williams$10,467,402
- Paula T Hammond$10,864,288
- Mehmet Fatih Yanik$10,178,635
- Tomasz S Mrowka$3,151,109
- James C Weaver$3,658,442
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularSliceResourcesBrainScreeningPharmaceutical PreparationsBrain TissueTransfectionStrokeNovel TherapeuticsDrug DevelopmentInnovationGenesPathway InteractionsMedicalTranslationsIschemic StrokeAreaInfarctionCellsAlzheimer&AposMultidisciplinaryDrug TargetingNeurons
Grant awards (14)
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,117,537
U01 · FY2024 · TR
Exploring synthetic lethality with a novel very high energy electron FLASH radiation beam$413,971
R21 · FY2024 · CA · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,135,383
U01 · FY2023 · TR
Duke Radiation Oncology and Radiology Stimulating Access to Research in Residency$558,805
R38 · FY2023 · CA · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,150,319
U01 · FY2022 · TR
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$638,289
R01 · FY2022 · NS
Duke Radiation Oncology and Radiology Stimulating Access to Research in Residency$487,274
R38 · FY2022 · CA · contact PI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform$1,195,189
U01 · FY2021 · TR
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$638,289
R01 · FY2021 · NS
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$638,289
R01 · FY2020 · NS
A 3D ex vivo orthotopic xenograft screening platform to identify radiosensitization targets and druggability in glioma$175,088
R21 · FY2020 · CA · contact PI
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction$639,088
R01 · FY2019 · NS
A 3D ex vivo orthotopic xenograft screening platform to identify radiosensitization targets and druggability in glioma$209,561
R21 · FY2019 · CA · contact PI
High-content screening for modifiers of the DNA damage response$163,163
R21 · FY2008 · NS